BRMS1 and neoplasm: Moreover, miR-346 induces tumor growth and progression by targeting breast cancer metastasis suppressor 1 (BRMS1) [41], while miR-3910 also promotes progression and migration of the disease via targeting MST1 and inducing the Hippo-YAP signaling pathway [42].